// App-Quantinova.ai

: CHARACTERIZATION OF MECHANISMS OF ACQUIRED VENETOCLAX-INSENSITIVITY IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Alexandra Niedermayer

Principal Investigators

  • Stefanie Enzenmueller

  • Eugen Tausch

  • Stephan Stilgenbauer

  • Felix Seyfried

  • Lueder Hinrich Meyer

  • Klaus-Michael Debatin

Medical Centers

  • Pediatrics and Adolescent Medicine,Ulm University Medical Center,Ulm,Germany

  • Internal Medicine III,Ulm University Hospital,Ulm,Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved